AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 APR 14 - (NewsRx.com & NewsRx.net) -- Sinovac Biotech Ltd. (SNVBF) announced that the Center for Disease Control of China and Sinovac are jointly working on the latest key science-technology project of the National "Tenth Five-Year-Plan" of China, called "Research and Development of a New Human Influenza Vaccine."
Sinovac has already finished the research protocol and has started working towards a vaccine.
The World Health Organization (WHO) influenza network will make the prototype bird flu virus available to vaccine makers around the world, according to Roy Wadia, from the WHO representative office in China.
As one of the vaccine makers, Sinovac is expecting to receive the virus strain from the WHO for its New Human Influenza Vaccine Research & Development Project.
Furthermore, on March 1 and 2, 2004, professionals from the WHO came to China for an "International Workshop on the Development of Vaccines for SARS and New Human Influenza Vaccines".
During the meeting, experts from Sinovac and more than 20 WHO professionals made presentations and discussed further collaboration about Inactivated SARS Vaccine and split Avian Flu vaccine development.
The WHO officials expressed their willingness to assist with the development of an ...